DE · 93M1.DE
MPH Health Care AG
- Sector
- Healthcare · Drug Manufacturers - Specialty & Generic
- Headquarters
- Berlin 12557
- Website
- mph-ag.de
Price · as of 2024-12-31
$21.10
Market cap 92.05M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $662.11 | +3,037.96% |
| Intrinsic Value(DCF) | $38.68 | +83.32% |
| Graham-Dodd Method(GD) | $84.32 | +299.63% |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | $14.13 | $137.94 | $1,191.98 | $0.00 | $76.12 |
| 2012 | $23.74 | $105.45 | $6,571.11 | $0.00 | $178.61 |
| 2013 | $20.11 | $579.28 | $581.40 | $0.00 | $29.87 |
| 2014 | $18.95 | $302.22 | $0.00 | $0.00 | $5.85 |
| 2015 | $16.20 | $701.95 | $2.90 | $100.11 | $525.87 |
| 2016 | $33.12 | $4,556.97 | $39.56 | $128.44 | $0.00 |
| 2017 | $34.07 | $527.99 | $10,575.80 | $75.41 | $2,056.08 |
| 2018 | $33.60 | $92.82 | $6,104.78 | $76.10 | $339.97 |
| 2019 | $31.47 | $437.40 | $96.36 | $46.38 | $0.00 |
| 2020 | $23.34 | $130.21 | $0.00 | $0.00 | $3,687.17 |
| 2021 | $18.42 | $228.96 | $31.68 | $34.46 | |
| 2022 | $12.65 | $376.77 | $41.63 | $85.72 | $426.06 |
| 2023 | $21.73 | $142.59 | $53.03 | $93.12 | $93.07 |
| 2024 | $22.17 | $662.11 | $58.18 | $84.32 | $0.00 |
AI valuation
Our deep-learning model estimates MPH Health Care AG's (93M1.DE) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $662.11
- Current price
- $21.10
- AI upside
- +3,037.96%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$38.68
+83.32% upside
Graham-Dodd
$84.32
+299.63% upside
Graham Formula
—
— upside
About MPH Health Care AG
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. In addition, it is involved in the provision of cytostatic solutions; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. The company was founded in 2008 and is based in Berlin, Germany. MPH Health Care AG is a subsidiary of Magnum AG.
- CEO
- Patrick Brenske
- Employees
- 2
- Beta
- 1.00
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($38.68 ÷ $21.10) − 1 = +83.32% (DCF, example).